DFB Technology

DFB Pharmaceuticals is a private Texas-based healthcare holding company that designs, invests in, and operates life science businesses. The company focuses on developing innovative therapies through its subsidiaries, most notably NanOlogy, which utilizes a proprietary submicron particle platform for oncology, and Phyton Biotech, a leader in plant cell fermentation for complex pharmaceutical ingredients. DFB has a significant track record of building and scaling healthcare companies, including the successful exits of DPT Laboratories and Healthpoint. Currently, the firm emphasizes advanced drug delivery systems and specialty manufacturing to address unmet medical needs in cancer and other therapeutic areas.